Dendreon is committed to supporting men with advanced prostate cancer.
A leading not-for-profit organization NCCN, recommends sipuleucel-T (PROVENGE) as a first-line treatment option in certain men with advanced prostate cancer (mCRPC).
The NCCN recommends sipuleucel-T (PROVENGE) may be used before or after certain other therapies for advanced prostate cancer (mCRPC). Even if you already received treatment for advanced prostate cancer, you may benefit from PROVENGE.
What is PROVENGE?
When should I consider PROVENGE?
What are the benefits of PROVENGE for me?
What side effects can occur with PROVENGE?
Is PROVENGE different from other therapies?
How does PROVENGE affect PSA levels?
How do I learn more about PROVENGE and advanced prostate cancer?
What kind of testing should I be getting to help manage my prostate cancer?
As a caregiver, how can I help?
Learn more about when and why PROVENGE might be the right treatment for you.
The first and only personalized immunotherapy for mCRPC.
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer V.3.2018. © National Comprehensive Cancer Network, Inc. 2018. All rights reserved. Accessed June 21, 2018. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Read and print questions that can help you start the PROVENGE conversation with your doctor.
PROVENGE® (sipuleucel-T) is a prescription medicine that is used to treat certain patients with advanced prostate cancer. PROVENGE is made from your own immune cells.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information.
Access this brochure to learn about PROVENGE and how it may help certain men with advanced prostate cancer (mCRPC) live longer.